Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Memphasys Ord Shs MPHSF

Healthcare Technology Biotechnology Scientific & Technical Instruments
Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:MPHSF)

Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting

Accesswire August 27, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI, MGOL on Behalf of Shareholders

PR Newswire July 15, 2024

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG - MOR

PR Newswire July 15, 2024

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

Business Wire July 12, 2024

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

PR Newswire July 8, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating MorphoSys AG Buyout

Newsfile June 27, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BEST, MOR, HCP, SQSP on Behalf of Shareholders

PR Newswire June 20, 2024

MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders

Business Wire June 20, 2024

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys' Minority Shareholders

Business Wire June 20, 2024
View More News ››

Opinion & Analysis (OTCPK:MPHSF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:MPHSF)

(MOR) Pivots Trading Plans and Risk Controls

News; $MOR (MOR) Pivots Trading Plans and Risk Controls2024-06-15 22:54:00 ET Stock Traders Daily has produced this trading report using...
whytestocks - June 15, 2024

MorphoSys AG Reports First Quarter 2024 Financial Results

Just In: $MOR MorphoSys AG Reports First Quarter 2024 Financial Results@ Entered into Business Combination Agreement to be acquired by...
whytestocks - April 29, 2024

MorphoSys Stock Soars After Report Says Novartis To Acquire

Breaking News: $MOR MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer | BenzingaMorphoSys AG (NASDAQ:MOR...
whytestocks - February 5, 2024

MorphoSys AG (NASDAQ: MOR) Near the Top of Equities by Perce

JUST IN: $MOR MorphoSys AG (NASDAQ: MOR) Near the Top of Equities by Percentage Gain on 2/5MorphoSys AG (NASDAQ: MOR) is one of today...
whytestocks - February 5, 2024

MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product

Just In: $MOR MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and...
whytestocks - January 30, 2024

Real stock price share value

13$
Nibinator - October 30, 2023
View more Bullboard ››

Nanalysis Scientific Corp.

Nanalysis Scientific Corp.

Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for ...
View More »